ORG 34517

Drug Profile

ORG 34517

Alternative Names: ORG-34517; SCH-900636

Latest Information Update: 28 Oct 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Organon
  • Developer Merck & Co; Organon; Pop Test
  • Class Antidepressants; Antineoplastics; Benzodioxoles; Chemosensitisers; Diagnostic agents; Phenanthrenes; Steroids
  • Mechanism of Action Glucocorticoid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Breast cancer
  • Discontinued Major depressive disorder

Most Recent Events

  • 25 Oct 2011 ORG 34517 is available for licensing as of 25 Oct 2011. http://www.poptestllc.com
  • 25 Oct 2011 Pop Test acquires ORG 34517 from Merck & Co.
  • 25 Oct 2011 Pharmacodynamics data from a preclinical trial in Breast cancer released by Pop Test
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top